Prasugrel 5 mg in the very elderly attenuates platelet inhibition but maintains noninferiority to prasugrel 10 mg in nonelderly patients: the GENERATIONS trial, a pharmacodynamic and pharmacokinetic study in stable coronary artery disease patients (Q34763095)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Prasugrel 5 mg in the very elderly attenuates platelet inhibition but maintains noninferiority to prasugrel 10 mg in nonelderly patients: the GENERATIONS trial, a pharmacodynamic and pharmacokinetic study in stable coronary artery disease patients |
scientific article |
Statements
1 reference
Prasugrel 5 mg in the very elderly attenuates platelet inhibition but maintains noninferiority to prasugrel 10 mg in nonelderly patients: the GENERATIONS trial, a pharmacodynamic and pharmacokinetic study in stable coronary artery disease patients (English)
1 reference
Paul A Gurbel
1 reference
Dominick J Angiolillo
1 reference
David Erlinge
1 reference
Stefan James
1 reference
Tomas L Lindahl
1 reference
Peter Svensson
1 reference
Jurrien M Ten Berg
1 reference
David P Foley
1 reference
Henrik Wagner
1 reference
Patricia B Brown
1 reference
Junxiang Luo
1 reference
Chunmei Zhou
1 reference
Brian A Moser
1 reference
Joseph A Jakubowski
1 reference
David S Small
1 reference
Kenneth J Winters
1 reference
7 June 2013
1 reference
1 reference
62
1 reference
7
1 reference
577-583
1 reference
Identifiers
1 reference
1 reference